Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kartner, Norbert
Riordan, John R.
and
Ling, Victor
1983.
Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines.
Science,
Vol. 221,
Issue. 4617,
p.
1285.
Twentyman, Peter R.
1983.
Bleomycin—mode of action with particular reference to the cell cycle.
Pharmacology & Therapeutics,
Vol. 23,
Issue. 3,
p.
417.
Hill, B. T.
1984.
Antitumor Drug Resistance.
Vol. 72,
Issue. ,
p.
673.
Urade, Masahiro
Sugi, Masakazu
and
Matsuya, Tokuzo
1988.
Further Characterization of Bleomycin‐resistant HeLa Cells and Analysis of Resistance Mechanism.
Japanese Journal of Cancer Research,
Vol. 79,
Issue. 4,
p.
491.
Urade, Masahiro
Sugi, Masakazu
and
Miyazaki, Tadashi
1988.
Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents.
Cancer,
Vol. 61,
Issue. 8,
p.
1501.
Lazo, John S.
Schisselbauer, John C.
Meandzua, Borlslav
and
Kennedy, Katherine A.
1989.
Initial single-strand DNA damage and cellular pharmacokinetics of bleomycin A2.
Biochemical Pharmacology,
Vol. 38,
Issue. 13,
p.
2207.
Lynch, Garrett R.
and
Lane, Montague
1989.
Cancer Management in Man.
p.
134.
Urade, Masahiro
Ogura, Takafumi
Mima, Takashi
and
Mafsuya, Tokuzo
1992.
Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity.
Cancer,
Vol. 69,
Issue. 10,
p.
2589.
Pron, Géraldine
Belehradek, Jean
Orlowski, Stéphane
and
Mir, Lluis M.
1994.
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity.
Biochemical Pharmacology,
Vol. 48,
Issue. 2,
p.
301.
Kutscher, Bernhard
Curt, Gregory A.
Allegra, Carmen J.
Fine, Robert L.
Mujagic, Hamza
Chao Yeh, Grace
and
Chabner, Bruce A.
2000.
Ullmann's Encyclopedia of Industrial Chemistry.
Bueschbell, Beatriz
Caniceiro, Ana Beatriz
Suzano, Pedro M.S.
Machuqueiro, Miguel
Rosário-Ferreira, Nícia
and
Moreira, Irina S.
2022.
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer.
Drug Resistance Updates,
Vol. 60,
Issue. ,
p.
100811.